NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivoTadepally Lakshmikanth, Francesco Colucci, Shannon Burke et al.|Journal of Clinical Investigation|2009Cited by 331
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Laurence Zitvogel, Meriem Messaoudene et al.|Cell Research|2019Cited by 246
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Alexander Roesch, Kilian Wistuba‐Hamprecht et al.|JCO Precision Oncology|2019Cited by 54
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanomaLuiza Martins Nascentes Melo, Iris Helfrich, Dayana Herrera-Rios et al.|Journal for ImmunoTherapy of Cancer|2023Cited by 31
ctDNA as a noninvasive monitoring tool in metastatic melanoma.Renáta Váraljai, Alexander Roesch, Kilian Wistuba‐Hamprecht et al.|Journal of Clinical Oncology|2019Cited by 0